Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.043 AUD 7.5% Market Closed
Market Cap: AU$94.2m

Net Margin

17.2%
Current
Improving
by 88.1%
vs 3-y average of -70.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17.2%
=
Net Income
AU$4.9m
/
Revenue
AU$28.4m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17.2%
=
Net Income
AU$4.9m
/
Revenue
AU$28.4m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Bioxyne Ltd
ASX:BXN
93.1m AUD
Loading...
FR
L'Oreal SA
PAR:OR
208.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
114.1B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
35.9B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
35.5B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
22.7B EUR
Loading...
JP
Kao Corp
TSE:4452
3T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
901.4B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 87% of companies in Australia
Percentile
87th
Based on 4 004 companies
87th percentile
17.2%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Bioxyne Ltd
Glance View

Market Cap
94.2m AUD
Industry
Consumer products

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

BXN Intrinsic Value
0.06 AUD
Undervaluation 29%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
17.2%
=
Net Income
AU$4.9m
/
Revenue
AU$28.4m
What is Bioxyne Ltd's current Net Margin?

The current Net Margin for Bioxyne Ltd is 17.2%, which is above its 3-year median of -70.9%.

How has Net Margin changed over time?

Over the last 3 years, Bioxyne Ltd’s Net Margin has increased from -106.6% to 17.2%. During this period, it reached a low of -145.2% on Dec 31, 2023 and a high of 17.2% on Jul 30, 2025.

Back to Top